Nontoxic Tumor-Targeting Optical Agents for Intraoperative Breast Tumor Imaging
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nontoxic Tumor-Targeting Optical Agents for Intraoperative Breast Tumor Imaging
Authors
Keywords
-
Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 65, Issue 10, Pages 7371-7379
Publisher
American Chemical Society (ACS)
Online
2022-05-12
DOI
10.1021/acs.jmedchem.2c00417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Image-guided surgery with a new tumour-targeting probe improves the identification of positive margins
- (2022) Masahide Goto et al. EBioMedicine
- Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
- (2021) Thu Ha Pham et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Advances in engineering near-infrared luminescent materials
- (2021) Christopher T. Jackson et al. iScience
- Solution structure of the anticancer p28 peptide in biomimetic medium
- (2021) Francesca Cantini et al. JOURNAL OF PEPTIDE SCIENCE
- The Impact of a Heterozygous SLCO1B3 Null Variant on the Indocyanine Green Retention Test
- (2020) Kazuya Anzai et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Nonclinical safety testing of imaging agents, contrast agents and radiopharmaceuticals
- (2020) Paul Baldrick JOURNAL OF APPLIED TOXICOLOGY
- Paclitaxel’s Mechanistic and Clinical Effects on Breast Cancer
- (2019) Tala M. Abu Samaan et al. Biomolecules
- Human epidermal growth factor coupled to different structural classes of cell penetrating peptides: A comparative study
- (2017) Jing Chen et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Margins in breast conserving surgery: The financial cost & potential savings associated with the new margin guidelines
- (2016) Lauren Singer et al. BREAST
- p28-Mediated Activation of p53 in G 2 –M Phase of the Cell Cycle Enhances the Efficacy of DNA Damaging and Antimitotic Chemotherapy
- (2016) Tohru Yamada et al. CANCER RESEARCH
- Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging
- (2016) Alisha V. DSouza et al. JOURNAL OF BIOMEDICAL OPTICS
- Phase I trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study
- (2016) Rishi R. Lulla et al. NEURO-ONCOLOGY
- Margin re-excision and local recurrence in invasive breast cancer: A cost analysis using a decision tree model
- (2015) Shoko E. Abe et al. JOURNAL OF SURGICAL ONCOLOGY
- Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
- (2015) Haiquan Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Discovery of a non-cationic cell penetrating peptide derived from membrane-interacting human proteins and its potential as a protein delivery carrier
- (2015) Hyo Young Kim et al. Scientific Reports
- A Quick Responsive Fluorogenic pH Probe for Ovarian Tumor Imaging
- (2015) Ching-Hsuan Tung et al. Theranostics
- Chirality Switching within an Anionic Cell-Penetrating Peptide Inhibits Translocation without Affecting Preferential Entry
- (2014) Tohru Yamada et al. MOLECULAR PHARMACEUTICS
- A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours
- (2013) M A Warso et al. BRITISH JOURNAL OF CANCER
- Toxicity of Magnetic Resonance Imaging Agents: Small Molecule and Nanoparticle
- (2013) Yongmin Chang et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- p28, an Anionic Cell-Penetrating Peptide, Increases the Activity of Wild Type and Mutated p53 without Altering Its Conformation
- (2013) Tohru Yamada et al. MOLECULAR PHARMACEUTICS
- Image-guided cancer surgery using near-infrared fluorescence
- (2013) Alexander L. Vahrmeijer et al. Nature Reviews Clinical Oncology
- Peptide-based targeting strategies for simultaneous imaging and therapy with nanovectors
- (2013) Antonella Accardo et al. POLYMER JOURNAL
- Surgical Margins in Lumpectomy for Breast Cancer — Bigger Is Not Better
- (2012) Monica Morrow et al. NEW ENGLAND JOURNAL OF MEDICINE
- Paclitaxel resistance is associated with switch from apoptotic to autophagic cell death in MCF-7 breast cancer cells
- (2012) G M A Ajabnoor et al. Cell Death & Disease
- Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity
- (2010) Patrina Gunness et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Preclinical pharmacokinetics, metabolism, and toxicity of azurin-p28 (NSC745104) a peptide inhibitor of p53 ubiquitination
- (2010) Lee Jia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Noncationic Peptides Obtained From Azurin Preferentially Enter Cancer Cells
- (2009) B. N. Taylor et al. CANCER RESEARCH
- A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells
- (2009) T. Yamada et al. MOLECULAR CANCER THERAPEUTICS
- Mouse xenograft models vs GEM models for human cancer therapeutics
- (2008) A. Richmond et al. Disease Models & Mechanisms
- Genistein protects the kidney from cisplatin-induced injury
- (2008) Mi Jeong Sung et al. KIDNEY INTERNATIONAL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now